Kazuko Shiozawa

Kakogawa, 6758555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

DOCK8-expressing T follicular helper cells newly generated beyond self-organized criticality cause systemic lupus erythematosus.

DOCK8-expressing T follicular helper cells newly generated beyond self-organized criticality cause systemic lupus erythematosus.

Journal: iScience

Published: May 12, 2021

Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.

Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.

Journal: Modern rheumatology

Published: September 08, 2017

A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell.

A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell.

Journal: The Journal of biological chemistry

Published: May 24, 2017

Erratum to: Predictors of poor sleep quality in patients with systemic lupus erythematosus.

Erratum to: Predictors of poor sleep quality in patients with systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: May 05, 2017

The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.

The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.

Journal: Lupus

Published: December 09, 2016

Predictors of poor sleep quality in patients with systemic lupus erythematosus.

Predictors of poor sleep quality in patients with systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: October 27, 2016

Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.

Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.

Journal: Modern rheumatology

Published: September 12, 2015

MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.

MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.

Journal: Arthritis research & therapy

Published: August 24, 2015

Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent.

Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent.

Journal: Rheumatology (Oxford, England)

Published: July 17, 2015

A study on the selection of DMARDs for the combination therapy with adalimumab.

A study on the selection of DMARDs for the combination therapy with adalimumab.

Journal: The Kobe journal of medical sciences

Published: September 14, 2012

Mixed connective tissue disease is distinct from systemic lupus erythematosus: study of major histocompatibility complex class I polypeptide-related sequence A and HLA gene polymorphisms.

Mixed connective tissue disease is distinct from systemic lupus erythematosus: study of major histocompatibility complex class I polypeptide-related sequence A and HLA gene polymorphisms.

Journal: Tissue antigens

Published: August 23, 2012

Shorter disease duration is important for tocilizumab to achieve Boolean remission.

Shorter disease duration is important for tocilizumab to achieve Boolean remission.

Journal: Modern rheumatology

Published: August 21, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026